Disposition of orally administered di-(2-ethylhexyl) phthalate and mono-(2-ethylhexyl) phthalate in the rat
- PMID: 4091646
- DOI: 10.1007/BF00324782
Disposition of orally administered di-(2-ethylhexyl) phthalate and mono-(2-ethylhexyl) phthalate in the rat
Abstract
The disposition of di-(2-ethylhexyl) phthalate (DEHP) and mono-(2-ethylhexyl) phthalate (MEHP) was studied in the rat. Three hours after a single oral dose of DEHP (2.8 g/kg), plasma concentrations of 8.8 +/- 1.7 micrograms/ml DEHP and 63.2 +/- 8.7 micrograms/ml MEHP were reached. MEHP levels declined with a half-life of 5.2 +/- 0.5 h. The ratio of the area under the plasma concentration-time curve of MEHP to that of DEHP was 16.1 +/- 6.1. When 14C-DEHP was administered, 19.3 +/- 3.3% of the radioactivity was excreted in the urine within 72 h, the rest being excreted in the faeces. The urinary excretion rate of total radioactivity declined with a half-life of 7.9 +/- 0.5 h. Single administration of MEHP (0.4 g/kg) resulted in plasma concentrations of 84.1 +/- 14.9 micrograms/ml 3 h after dosing; the half-life of MEHP was 5.5 +/- 1.1 h. Multiple dosing with DEHP (2.8 g/kg/day) for 7 consecutive days produced no accumulation of DEHP or MEHP in plasma.
Similar articles
-
Effects of route of administration and repetitive dosing on the disposition kinetics of di(2-ethylhexyl) phthalate and its mono-de-esterified metabolite in rats.Toxicol Appl Pharmacol. 1985 Jun 30;79(2):246-56. doi: 10.1016/0041-008x(85)90346-1. Toxicol Appl Pharmacol. 1985. PMID: 4002226
-
The metabolism of di(2-ethylhexyl) phthalate (DEHP) and mono-(2-ethylhexyl) phthalate (MEHP) in rats: in vivo and in vitro dose and time dependency of metabolism.Toxicol Appl Pharmacol. 1985 Aug;80(1):11-22. doi: 10.1016/0041-008x(85)90096-1. Toxicol Appl Pharmacol. 1985. PMID: 4024100
-
Non-linearities in the pharmacokinetics of di-(2-ethylhexyl) phthalate and metabolites in male rats.Arch Toxicol. 1985 Dec;58(2):72-7. doi: 10.1007/BF00348312. Arch Toxicol. 1985. PMID: 4091659
-
Toxicity and metabolism of monoethylhexyl phthalate and diethylhexyl phthalate: a survey of recent literature.J Toxicol Environ Health. 1982 Jan;9(1):141-52. doi: 10.1080/15287398209530149. J Toxicol Environ Health. 1982. PMID: 7038132 Review.
-
Di(2-ethylhexyl)phthalate (DEHP): human metabolism and internal exposure-- an update and latest results.Int J Androl. 2006 Feb;29(1):155-65; discussion 181-5. doi: 10.1111/j.1365-2605.2005.00607.x. Int J Androl. 2006. PMID: 16466535 Review.
Cited by
-
Determination and pharmacokinetics of di-(2-ethylhexyl) phthalate in rats by ultra performance liquid chromatography with tandem mass spectrometry.Molecules. 2013 Sep 16;18(9):11452-66. doi: 10.3390/molecules180911452. Molecules. 2013. PMID: 24043141 Free PMC article.
-
Effects of co-administration of di(2-ethylhexyl)phthalate and testosterone on several parameters in the testis and pharmacokinetics of its mono-de-esterified metabolite.Arch Toxicol. 1989;63(4):289-95. doi: 10.1007/BF00278642. Arch Toxicol. 1989. PMID: 2764717
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources